面肌痉挛:神经外科视角
本文从神经外科视角综述面肌痉挛(HFS)的治疗。系列肉毒毒素注射可暂时缓解痉挛且被广泛报道高效,而微血管减压术(MVD)有治愈潜力,但北美利用率仅约10%,许多患者未获充分告知。多数MVD神经外科医生年手术量低,但关注技术细节和解剖可获良好安全性和成功率。
要点
- 系列肉毒毒素注射可暂时缓解面肌痉挛,被广泛报道高效。
- 微血管减压术有治愈潜力,但北美利用率仅约10%。
- 许多患者未获充分告知微血管减压术这一手术选择。
核心结论
- 关注更好地告知患者并优化手术结局,应使神经外科在面肌痉挛的治疗和治愈中发挥更大作用。
研究设计与样本
- 本文为神经外科视角的综述,未报告系统检索范围。
主要发现
- 系列肉毒毒素注射提供暂时性痉挛缓解,被广泛报道为高效。
- 微血管减压术有极好的疾病治愈潜力,但北美利用率仍很低(约10%)。
- 许多患者未获充分告知微血管减压术这一手术选择。
- 多数微血管减压术神经外科医生年手术量低,但关注技术细节和对目标面神经根出区(root exit zone)的解剖理解可获良好安全性和成功率。
临床怎么用
- 原文结论指出关注更好地告知患者并优化手术结局,应使神经外科在面肌痉挛的治疗和治愈中发挥更大作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hemifacial spasm (HFS) causes both physical and psychological disabilities that significantly impact quality of life. Medical management with serial botulinum toxin injections provides transient spasm relief and is widely reported as highly effective, as compared to no treatment. While there is an excellent potential for disease cure with microvascular decompression (MVD) surgery, utilization rates remain very low in North America (approximately 10%) and many patients are not adequately informed of this surgical option. Although the majority of MVD neurosurgeons maintain a low annual case volume, excellent safety and success rates can be achieved with attention to technical nuances and anatomical appreciation of the target facial root exit zone. Attention to better informing patients and optimizing surgical outcomes should lead to a greater role for neurosurgery in the treatment and cure of HFS.
引用
- Kaufmann AM. Hemifacial spasm: a neurosurgical perspective. J Neurosurg. 2023. PMID: 37439481. doi:10.3171/2023.5.JNS221898
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。